Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting.

Kathy Baisley ORCID logo; Jared M Baeten; James P Hughes; Deborah J Donnell; Jing Wang; Richard Hayes ORCID logo; Deborah Watson Jones; Connie Celum; (2013) Summary measures of adherence using pill counts in two HIV prevention trials: the need for standardisation in reporting. AIDS and behavior, 17 (9). pp. 3108-3119. ISSN 1090-7165 DOI: 10.1007/s10461-013-0542-9
Copy

For trials of user-dependent HIV prevention products, accurate adherence measurements are essential to interpret and compare results across trials. We used pill count data from two recent HIV prevention trials of herpes simplex virus type 2 (HSV-2) suppression, to show that estimates of adherence vary substantially depending on assumptions that are made in analysing pill count data. We associate calculated adherence with biological markers of anti-HSV-2 activity. In both trials, calculated adherence varied considerably, depending on the summary measure used, and the handling of intervals with apparent 'over-adherence' (fewer pills returned than expected), and unreturned pills. Intervals of apparent over-adherence were associated with reduced antiviral effects on biological markers of herpes reactivation, indicating these are likely to represent periods of non-adherence. Our results demonstrate the clear need for standardisation in reporting of adherence data that are based on pill counts.


picture_as_pdf
Summary measures of adherence using pill counts in two HIV prevention trials the need for standardisation in reporting.pdf
subject
Published Version
Available under Creative Commons: 3.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads